Protein Uncoupling as an Innovative Practice in Diabetes Mellitus Treatment: A Metabolic Disorder
GPCR News
- Sep 1, 2022
- 1 min
Hear the sounds: the role of G protein-coupled receptors in the cochlea
- Aug 1, 2022
- 1 min
Opioid Ligands Addressing Unconventional Binding Sites and More Than One Opioid Receptor Subtype
- Aug 1, 2022
- 1 min
Dopamine D 1 receptor-mediated β-arrestin signaling: Insight from pharmacology, biology, behavior...
- Aug 1, 2022
- 1 min
Structural basis of GPCR coupling to distinct signal transducers: implications for biased signaling
- Aug 1, 2022
- 1 min
Deciphering the signaling mechanisms of β-arrestin1 and β-arrestin2 in regulation of cancer cell...
- Aug 1, 2022
- 1 min
Diversity and specificity in location-based signaling outputs of neuronal GPCRs
- Aug 1, 2022
- 1 min
Posttranslational modifications in GPCR internalization
- Aug 1, 2022
- 1 min
GRK2 in cardiovascular disease and its potential as a therapeutic target
- Aug 1, 2022
- 1 min
Targeting CXCR1 and CXCR2 receptors in cardiovascular diseases
- Aug 1, 2022
- 1 min
Adenosine receptor signalling in Alzheimer's disease
- Aug 1, 2022
- 1 min
AlphaFold2 versus experimental structures: evaluation on G protein-coupled receptors
- Aug 1, 2022
- 1 min
Molecular targets of psychedelic-induced plasticity
- Aug 1, 2022
- 1 min
Molecular insights into psychedelic drug action
- Aug 1, 2022
- 1 min
Community guidelines for GPCR ligand bias: IUPHAR review 32
- Aug 1, 2022
- 1 min
TRPM3 in the eye and in the nervous system - from new findings to novel mechanisms
- Aug 1, 2022
- 1 min
Developing the Cannabinoid Receptor 2 (CB2) pharmacopeia: past, present, and future
- Dec 26, 2021
- 1 min
G-protein-coupled receptors as therapeutic targets for glioblastoma
- Dec 21, 2021
- 1 min
Phospholipid Scrambling by G Protein-Coupled Receptors
- Dec 20, 2021
- 1 min
Prostaglandin signaling in ciliogenesis and development